Okanoue T - Search Results

1

Lack of evidence for leukocyte maternal microchimerism in primary biliary cirrhosis.

Nomura K, Sumida Y, Yoh T, Morita A, Matsumoto Y, Taji S, Yoshida N, Minami M, Itoh Y, Horiike S, Kataoka K, Taniwaki M, Okanoue T. Nomura K, et al. Among authors: okanoue t. World J Gastroenterol. 2004 Aug 15;10(16):2415-6. doi: 10.3748/wjg.v10.i16.2415. World J Gastroenterol. 2004. PMID: 15285032 Free PMC article.

2

Elevated interleukin-6 and gamma-globulin during interferon therapy of hepatitis B.

Itoh Y, Okanoue T, Enjyo F, Morimoto M, Takeuchi T, Kagawa K, Kashima K. Itoh Y, et al. Among authors: okanoue t. Am J Gastroenterol. 1992 Oct;87(10):1485-7. Am J Gastroenterol. 1992. PMID: 1384310

3

Functional heterogeneity of rat liver macrophages: interleukin-1 secretion and Ia antigen expression in contrast with phagocytic activity.

Itoh Y, Okanoue T, Morimoto M, Nagao Y, Mori T, Hori N, Kagawa K, Kashima K. Itoh Y, et al. Among authors: okanoue t. Liver. 1992 Feb;12(1):26-33. doi: 10.1111/j.1600-0676.1992.tb00551.x. Liver. 1992. PMID: 1564982

4

Regulation of hepatocyte albumin and alpha 1-acid glycoprotein secretion by monokines, dexamethasone, and nitric oxide synthase pathway: significance of activated liver nonparenchymal cells.

Itoh Y, Okanoue T, Enjo F, Sakamoto S, Takami S, Yasui K, Kagawa K, Kashima K. Itoh Y, et al. Among authors: okanoue t. Dig Dis Sci. 1994 Apr;39(4):851-60. doi: 10.1007/BF02087433. Dig Dis Sci. 1994. PMID: 7512018

5

PreS1 deleted variants of hepatitis B virus in patients with chronic hepatitis.

Nakajima E, Minami M, Ochiya T, Kagawa K, Okanoue T. Nakajima E, et al. Among authors: okanoue t. J Hepatol. 1994 Mar;20(3):329-35. doi: 10.1016/s0168-8278(94)80003-0. J Hepatol. 1994. PMID: 7516949

6

[Autoimmune disorders in interferon therapy].

Okanoue T, Itoh Y, Yasui K. Okanoue T, et al. Nihon Rinsho. 1994 Jul;52(7):1924-8. Nihon Rinsho. 1994. PMID: 7521440 Review. Japanese.

7

Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon.

Itoh Y, Okanoue T, Sakamoto S, Nishioji K, Yasui K, Sakamoto M, Kashima K. Itoh Y, et al. Among authors: okanoue t. Dig Dis Sci. 1995 Nov;40(11):2423-30. doi: 10.1007/BF02063248. Dig Dis Sci. 1995. PMID: 7587825

8

Serum autoantibody against interleukin-1 alpha is unrelated to the etiology or activity of liver disease but can be raised by interferon treatment.

Itoh Y, Okanoue T, Sakamoto S, Nishioji K, Kashima K, Ohmoto Y. Itoh Y, et al. Among authors: okanoue t. Am J Gastroenterol. 1995 May;90(5):777-82. Am J Gastroenterol. 1995. PMID: 7733087

9

Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease.

Itoh Y, Okanoue T, Enjyo F, Sakamoto S, Ohmoto Y, Hirai Y, Kagawa K, Kashima K. Itoh Y, et al. Among authors: okanoue t. J Hepatol. 1994 Oct;21(4):527-35. doi: 10.1016/s0168-8278(94)80097-9. J Hepatol. 1994. PMID: 7814798

10

Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.

Hori N, Okanoue T, Sawa Y, Itoh Y, Mori T, Takami S, Kashima K. Hori N, et al. Among authors: okanoue t. J Gastroenterol. 1994 Aug;29(4):460-8. doi: 10.1007/BF02361244. J Gastroenterol. 1994. PMID: 7951857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters